Photo by jrkorpa from unsplash
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated disease that targets the myelin sheaths of the peripheral nerves. Fingolimod is a sphingosine 1 phosphate (S1P) receptor antagonist with a high… Click to show full abstract
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated disease that targets the myelin sheaths of the peripheral nerves. Fingolimod is a sphingosine 1 phosphate (S1P) receptor antagonist with a high affinity for S1P receptors through the Akt–mTOR pathway, and prior research has suggested that it might be helpful in autoimmune illnesses.
Keywords:
autoimmune neuritis;
chronic experimental;
experimental autoimmune;
ameliorates chronic;
akt mtor;
fingolimod ameliorates
Journal Title: Brain and Behavior
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Brain and Behavior
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!